Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.
about
Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders.Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspects.Recombinant activated factor VII in clinical practice: a 2014 update.Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomesSurgery in patients with inherited bleeding disorders.The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors.U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors.Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa.Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding.How I treat inhibitors in haemophilia.
P2860
Q37185097-62CBC47F-2A8C-4A2E-8212-F6658485DC32Q37778291-36120DCB-4BD6-44D2-9C72-F94B8C6A5DC6Q37845931-3BAD6DF6-E080-4DDD-96A7-D340AC4E0D99Q38038332-C31ABBAB-75A1-4506-A300-A926475E3D5DQ38228494-92D668F8-C071-4641-BCAE-A23AF9A2C0C6Q38235951-4060C8AD-ED47-4C69-8C27-44F0723C01E6Q38273796-94F18D11-4DFE-4B1A-8B8C-EDA14101F03EQ39420691-A7159D11-F22A-49A5-8E7B-807524402354Q39675759-0B6FBEA6-D19D-40BA-8B04-B5F461A3448FQ45838031-B020CAA8-D190-4876-B882-483AD8CFA6D2Q45855177-25254298-07D1-46DF-9988-B142814E1824Q45865332-DB5BB8B9-334B-48C5-A44D-25D86838F1CFQ45870435-A95AAB74-72D5-41A5-913C-9DB9B6911DE9Q45879927-C3572F80-5CCB-45C8-BD01-900D82E51A93
P2860
Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recombinant activated factor V ...... y: a review of the literature.
@en
Recombinant activated factor V ...... y: a review of the literature.
@nl
type
label
Recombinant activated factor V ...... y: a review of the literature.
@en
Recombinant activated factor V ...... y: a review of the literature.
@nl
prefLabel
Recombinant activated factor V ...... y: a review of the literature.
@en
Recombinant activated factor V ...... y: a review of the literature.
@nl
P2093
P2860
P1433
P1476
Recombinant activated factor V ...... y: a review of the literature.
@en
P2093
A Obergfell
M-K Auvinen
P2860
P304
P356
10.1111/J.1365-2516.2007.01617.X
P577
2007-12-12T00:00:00Z